Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K W Brunner

Showing results (121-130 of 148) with videos related to

Pageof 15
Sort By:
Schweizerische Medizinische Wochenschrift|December 31, 1988
[Loco-regional recurrence following surgery of breast carcinoma: prognostic factors and therapeutic consequences]K W Brunner, F Harder, R Greiner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapyR A Joss, R L Galeazzi, A Bischoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observationM Waeber, M Castiglione-Gertsch, D Dietrich, et al.
Cancer|June 1, 1977
Combined chemo- and hormonal therapy in advanced breast cancerK W Brunner, R W Sonntag, P Alberto, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Simultaneous hormone- and chemotherapy, compared with hormone therapy followed by chemotherapy in the treatment of metastasising mammary carcinoma--preliminary results of a current studyF Cavalli, P Alberto, W F Jungi, et al.
Schweizerische Medizinische Wochenschrift|July 8, 1980
[Phase-II-study with vindesine (desacetyl-vinblastine-amide-sulfate) in advanced malignant diseases]A Goldhirsch, M Beer, R W Sonntag, et al.
Schweizerische Medizinische Wochenschrift|July 2, 1977
[VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma]H J Ryssel, E Hasler, R W Sonntag, et al.
Clinical Pharmacology and Therapeutics|June 1, 1986
The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trialR A Joss, R L Galeazzi, A K Bischoff, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1984
Pathologic data of prognostic significance for remission induction in advanced ovarian carcinomaB W Davis, A Goldhirsch, G W Locher, et al.
Schweizerische Medizinische Wochenschrift|December 9, 1978
[Simultaneous hormonal and drug therapy, compared to hormonal therapy, followed by chemotherapy, in the treatment of metastasizing breast neoplasms. Preliminary results of an ongoing study]F Cavalli, P Alberto, W F Jungi, et al.
Pageof 15

Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
Schweizerische Medizinische Wochenschrift|December 31, 1988
[Loco-regional recurrence following surgery of breast carcinoma: prognostic factors and therapeutic consequences]K W Brunner, F Harder, R Greiner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapyR A Joss, R L Galeazzi, A Bischoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observationM Waeber, M Castiglione-Gertsch, D Dietrich, et al.
Cancer|June 1, 1977
Combined chemo- and hormonal therapy in advanced breast cancerK W Brunner, R W Sonntag, P Alberto, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Simultaneous hormone- and chemotherapy, compared with hormone therapy followed by chemotherapy in the treatment of metastasising mammary carcinoma--preliminary results of a current studyF Cavalli, P Alberto, W F Jungi, et al.
Schweizerische Medizinische Wochenschrift|July 8, 1980
[Phase-II-study with vindesine (desacetyl-vinblastine-amide-sulfate) in advanced malignant diseases]A Goldhirsch, M Beer, R W Sonntag, et al.
Schweizerische Medizinische Wochenschrift|July 2, 1977
[VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma]H J Ryssel, E Hasler, R W Sonntag, et al.
Clinical Pharmacology and Therapeutics|June 1, 1986
The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trialR A Joss, R L Galeazzi, A K Bischoff, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1984
Pathologic data of prognostic significance for remission induction in advanced ovarian carcinomaB W Davis, A Goldhirsch, G W Locher, et al.
Schweizerische Medizinische Wochenschrift|December 9, 1978
[Simultaneous hormonal and drug therapy, compared to hormonal therapy, followed by chemotherapy, in the treatment of metastasizing breast neoplasms. Preliminary results of an ongoing study]F Cavalli, P Alberto, W F Jungi, et al.
Pageof 15